--- title: "08:31 ETMoveFitRx Launches Clinical Intelligence Layer to Establish Exercise as a Medical Standard of Care" type: "News" locale: "en" url: "https://longbridge.com/en/news/279044619.md" description: "MoveFitRx has announced the launch of a health technology platform aimed at integrating exercise into clinical care as a validated prescription. This HIPAA-compliant portal allows physicians to prescribe exercise based on patient diagnoses, addressing the disconnect between exercise and formal healthcare. The platform focuses on key health areas and verifies patient adherence digitally. A clinical pilot is set for Spring 2026 in San Diego, coinciding with strategic briefings at the Health & Fitness Association National Conference. MoveFitRx aims to treat exercise with the same rigor as pharmaceutical interventions." datetime: "2026-03-13T12:32:17.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/279044619.md) - [en](https://longbridge.com/en/news/279044619.md) - [zh-HK](https://longbridge.com/zh-HK/news/279044619.md) --- # 08:31 ETMoveFitRx Launches Clinical Intelligence Layer to Establish Exercise as a Medical Standard of Care _New platform connects clinicians, patients, and fitness infrastructure to prescribe and verify exercise as medicine_ , /PRNewswire/ -- MoveFitRx, a health technology platform designed to bridge the gap between clinical care and physical activity, today announced its upcoming launch. By transforming exercise from a general recommendation into a validated prescription, MoveFitRx is building the infrastructure to establish movement as a formal clinical Standard of Care. While exercise is proven medicine for preventing and treating chronic disease, it has remained disconnected from formal healthcare due to a lack of objective verification. MoveFitRx addresses this systemic barrier through a HIPAA-compliant clinical portal that allows physicians to convert a patient diagnosis into a structured, diagnosis-specific prescription. "Healthcare has incredible tools for prescribing medication, but has lacked the infrastructure to prescribe, track, and validate movement," says Garrett Borunda, Founder and CEO of MoveFitRx. "By providing doctors with validated evidence of adherence, we are enabling the healthcare system to treat exercise with the same clinical rigor as a pharmaceutical intervention." The platform focuses on high-impact health transitions, including Metabolic Health, Mental Wellness, and Women's Health. Patient adherence is digitally verified through integrated systems, providing clinicians with the objective documentation necessary to monitor progress and support Remote Therapeutic Monitoring (RTM) workflows. MoveFitRx is currently activating its Spring 2026 roadmap, highlighted by an upcoming 50-patient live clinical pilot in San Diego to verify clinical-to-machine data flow. This rollout coincides with strategic briefings for fitness executives and investors at the Health & Fitness Association (HFA) National Conference in San Diego. MoveFitRx is led by Garrett Borunda, an innovation architect and Apple alum with 12 years of executive leadership at global fitness leaders EGYM, 24 Hour Fitness, and LA Fitness. Borunda, a Stanford University graduate, holds a patent for ultra-low delay reference decoders and has developed the patent-pending MoveFitRx Logic Engine. The company's strategic advisory board further leverages deep operational expertise from McKinsey, PWC, Harvard, and Princeton. For more information on MoveFitRx please visit MoveFitRx.com and follow us on Linkedin. **About MoveFitRx** MoveFitRx is a health technology company building the infrastructure to prescribe, track, and validate exercise as medicine. The platform connects clinicians, patients, and fitness facilities to enable verified exercise prescriptions designed to improve health outcomes while generating objective documentation for modern healthcare systems. Media Contact: Jaime Zimmerman / \[email protected\] / 216-299-1009 SOURCE MoveFitRx ### Related Stocks - [XLV.US](https://longbridge.com/en/quote/XLV.US.md) - [IHF.US](https://longbridge.com/en/quote/IHF.US.md) - [VHT.US](https://longbridge.com/en/quote/VHT.US.md) - [IDNA.US](https://longbridge.com/en/quote/IDNA.US.md) - [XHS.US](https://longbridge.com/en/quote/XHS.US.md) - [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md) - [PLNT.US](https://longbridge.com/en/quote/PLNT.US.md) ## Related News & Research - [Sino Biopharmaceutical Receives US Regulatory Nod to Begin Trials of Anti Tumor Drug](https://longbridge.com/en/news/282121816.md) - [Anthem Blue Cross and Blue Shield and Mount Sinai Health System Reach New Multi-Year Agreement](https://longbridge.com/en/news/282626767.md) - [20:28 ETJunction Collaborates with GRAIL to Power Scalable Access to the Galleri® Multi-Cancer Early Detection Test](https://longbridge.com/en/news/282264930.md) - [Fitness and health app MyFitnessPal explores sale, sources say](https://longbridge.com/en/news/282240099.md) - [Oragenics Doses First Patient In Phase 2a Trial For Brain Injury Drug ONP-002](https://longbridge.com/en/news/282660503.md)